Free Trial
NASDAQ:RCEL

AVITA Medical (RCEL) Stock Price, News & Analysis

AVITA Medical logo
$13.05 +0.09 (+0.69%)
(As of 11/20/2024 ET)

About AVITA Medical Stock (NASDAQ:RCEL)

Key Stats

Today's Range
$12.95
$13.82
50-Day Range
$9.70
$13.05
52-Week Range
$7.51
$18.93
Volume
184,340 shs
Average Volume
182,092 shs
Market Capitalization
$342.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.50
Consensus Rating
Hold

Company Overview

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

AVITA Medical Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
28th Percentile Overall Score

RCEL MarketRank™: 

AVITA Medical scored higher than 28% of companies evaluated by MarketBeat, and ranked 828th out of 963 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    AVITA Medical has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    AVITA Medical has only been the subject of 1 research reports in the past 90 days.

  • Read more about AVITA Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for AVITA Medical are expected to grow in the coming year, from ($2.35) to ($1.36) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of AVITA Medical is -5.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of AVITA Medical is -5.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    AVITA Medical has a P/B Ratio of 6.80. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about AVITA Medical's valuation and earnings.
  • Percentage of Shares Shorted

    4.83% of the float of AVITA Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    AVITA Medical has a short interest ratio ("days to cover") of 11.3, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in AVITA Medical has recently decreased by 11.19%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    AVITA Medical does not currently pay a dividend.

  • Dividend Growth

    AVITA Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.83% of the float of AVITA Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    AVITA Medical has a short interest ratio ("days to cover") of 11.3, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in AVITA Medical has recently decreased by 11.19%, indicating that investor sentiment is improving significantly.
  • Search Interest

    7 people have searched for RCEL on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, AVITA Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.82% of the stock of AVITA Medical is held by insiders.

  • Percentage Held by Institutions

    Only 27.66% of the stock of AVITA Medical is held by institutions.

  • Read more about AVITA Medical's insider trading history.
Receive RCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AVITA Medical and its competitors with MarketBeat's FREE daily newsletter.

RCEL Stock News Headlines

Watch this before it gets removed
If you missed it, my emergency election broadcast is now available - but will be removed soon
AVITA Medical to Host Investor Webinar Briefing
AVITA Medical Reports Third Quarter Financial Results
AVITA Medical, Inc. (AVHHL)
See More Headlines

RCEL Stock Analysis - Frequently Asked Questions

AVITA Medical's stock was trading at $13.72 at the beginning of the year. Since then, RCEL shares have decreased by 4.9% and is now trading at $13.05.
View the best growth stocks for 2024 here
.

AVITA Medical, Inc. (NASDAQ:RCEL) announced its quarterly earnings data on Thursday, November, 7th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.41) by $0.21. The business had revenue of $19.55 million for the quarter, compared to the consensus estimate of $19.65 million. AVITA Medical had a negative net margin of 95.47% and a negative trailing twelve-month return on equity of 194.69%.

Top institutional investors of AVITA Medical include Geode Capital Management LLC (2.27%), State Street Corp (1.98%), Essex Investment Management Co. LLC (0.90%) and Jane Street Group LLC (0.34%). Insiders that own company stock include Michael S Perry, Donna Shiroma, Jeremy Curnock Cook and James Corbett.
View institutional ownership trends
.

Shares of RCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that AVITA Medical investors own include Invesco QQQ (QQQ), SPDR S&P 500 ETF Trust (SPY), SPDR Dow Jones Industrial Average ETF Trust (DIA), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD) and Tesla (TSLA).

Company Calendar

Last Earnings
11/07/2024
Today
11/20/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
2/27/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:RCEL
Fax
N/A
Employees
130
Year Founded
2008

Price Target and Rating

Average Stock Price Target
$16.50
High Stock Price Target
$21.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+26.4%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$-35,380,000.00
Pretax Margin
-95.39%

Debt

Sales & Book Value

Annual Sales
$50.14 million
Book Value
$1.92 per share

Miscellaneous

Free Float
25,741,000
Market Cap
$342.17 million
Optionable
Optionable
Beta
1.54

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

This page (NASDAQ:RCEL) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners